Breaking News Instant updates and real-time market news.

2020-06-09 08:21:48 DIA Diamonds Fund ETF $276.21 / +4.69 (+1.73%) 08:21 06/09/20 06/09 08:21 06/09/20 08:21	Diamonds Fund ETF: Pivot points The following are the pivot points for the Diamonds Fund ETF (DIA). Pivot High: $278.07, Pivot Low: $274.59. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

2020-06-09 08:21:48

DIA

Diamonds Fund ETF

$276.21 / +4.69 (+1.73%)

08:21

06/09/20

06/09

08:21

06/09/20

08:21

Diamonds Fund ETF: Pivot points

The following are the pivot points for the Diamonds Fund ETF (DIA). Pivot High: $278.07, Pivot Low: $274.59. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Hot Stocks	Abcam says implementation of strategy remains within expectations » 07:30 03/08/21 03/08 07:30 03/08/21 07:30 ABCM Abcam $21.10 / +0.13 (+0.62%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ABCM Abcam $21.10 / +0.13 (+0.62%) 07:29 Today Abcam announces change of accounting reference date 11/03/20 Abcam to retain existing LTIP metrics, targets ABCM Abcam $21.10 / +0.13 (+0.62%) 01/12/21 RBC Capital Abcam upgraded to Outperform from Sector Perform at RBC Capital 11/16/20 William Blair Abcam initiated with an Outperform at William Blair 11/16/20 Fly Intel: Top five analyst initiations 11/16/20 Morgan Stanley Abcam initiated with an Equal Weight at Morgan Stanley ABCM Abcam $21.10 / +0.13 (+0.62%) 07:28 Today Abcam reports 1H adjusted EPS 8.1p vs. 13p last year 01/11/21 Abcam sees 1H revenue GBP147.5M vs. GBP138.2M last year 22 Oct ABCM Abcam $21.10 / +0.13 (+0.62%) 10/25/20 Opening Day: McAfee returns to public market with $740M IPO 09:00 Today Abcam - ABCM
Initiation	Bumble initiated with an Outperform at Cowen » 07:30 03/08/21 03/08 07:30 03/08/21 07:30 BMBL Bumble $61.93 / +2.41 (+4.05%) Cowen analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events Options BMBL Bumble $61.93 / +2.41 (+4.05%) 06:53 Today Morgan Stanley Bumble initiated with an Equal Weight at Morgan Stanley 06:20 Today Citi Bumble initiated with a Buy at Citi 06:00 Today Stifel Bumble initiated with a Buy at Stifel 05:05 Today Goldman Sachs Bumble initiated with a Neutral at Goldman Sachs 11 Feb BMBL Bumble $61.93 / +2.41 (+4.05%) 03/04/21 Snowflake, Qualcomm upgrades among today's top calls on Wall Street 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 03/10/21 Bumble - BMBL BMBL Bumble $61.93 / +2.41 (+4.05%) 02/18/21 Fourteen new option listings and one option delisting on February 18th
Downgrade	PRA Health downgraded to Sector Weight at KeyBanc » 07:30 03/08/21 03/08 07:30 03/08/21 07:30 PRAH PRA Health $146.32 / +3.555 (+2.49%) , ICLR Icon $180.16 / +8.48 (+4.94%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PRAH ICLR PRAH PRA Health $146.32 / +3.555 (+2.49%) 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 12/02/20 Appili Therapeutics doses first participant in Avigan trial ICLR Icon $180.16 / +8.48 (+4.94%) 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/16/21 Icon provided update on its CYTO-200 portfolio of clinical programs 01/04/21 Icon provides trial services to Pfizer, BioNTech COVID-19 vaccine program PRAH ICLR PRAH PRA Health $146.32 / +3.555 (+2.49%) 05:57 Today KeyBanc PRA Health downgraded to Sector Weight from Overweight at KeyBanc 03/02/21 Barclays Icon initiated with an Equal Weight at Barclays 03/01/21 UBS Icon upgraded to Buy from Neutral at UBS 02/26/21 Truist Icon upgraded to Buy from Hold at Truist ICLR Icon $180.16 / +8.48 (+4.94%) 05:24 Today Baird Icon upgraded to Outperform from Neutral at Baird 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays Icon initiated with an Equal Weight at Barclays 03/02/21 Barclays Icon initiated with an Equal Weight at Barclays PRAH ICLR PRAH PRA Health $146.32 / +3.555 (+2.49%) 02/24/21 PRA Health reports Q4 adjusted EPS $1.55, consensus $1.47 11/04/20 PRA Health raises FY20 adj. EPS view to $4.61-$4.71 from $4.35-$4.55 11/04/20 PRA Health reports Q3 adj. EPS $1.30, consensus $1.12 ICLR Icon $180.16 / +8.48 (+4.94%) 02/24/21 Icon sees FY21 adjusted EPS $8.10-$8.50, consensus $7.94 02/24/21 Icon reports Q4 adjusted EPS $1.90, consensus $1.83 10/21/20 Icon raises FY20 revenue view to $6.35-$6.50 from $6.00-$6.50 10/21/20 Icon reports Q3 EPS $1.72, consensus $1.53 PRAH ICLR PRAH PRA Health $146.32 / +3.555 (+2.49%) 02/24/21 Fly Intel: Pre-market Movers ICLR Icon $180.16 / +8.48 (+4.94%) 02/24/21 Fly Intel: Pre-market Movers
Hot Stocks	NewHold Investment Corp (Units) trading resumes 07:30 03/08/21 03/08 07:30 03/08/21 07:30
Hot Stocks	NewHold Investment Corp (Class A Stock) trading resumes 07:30 03/08/21 03/08 07:30 03/08/21 07:30 NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) ShowHide Related Items >><< Company News Periodicals NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 07:21 Today Evolv Technology to be publicly traded through NewHold Investment Corp. merger 07:01 Today NewHold Investment Corp (Class A Stock) trading halted, news dissemination 03/07/21 Fly Intel: Top five weekend stock stories NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 03/07/21 Evolv going public in $1.7B SPAC merger, WSJ reports

Initiation	Bioventus initiated with an Overweight at JPMorgan » 07:29 03/08/21 03/08 07:29 03/08/21 07:29 BVS Bioventus $11.50 / -0.48 (-4.01%) JPMorgan analyst Robbie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events BVS Bioventus $11.50 / -0.48 (-4.01%) 06:51 Today Morgan Stanley Bioventus initiated with an Overweight at Morgan Stanley 05:48 Today Canaccord Bioventus initiated with a Buy at Canaccord 05:00 Today Goldman Sachs Bioventus initiated with a Buy at Goldman Sachs 11 Feb BVS Bioventus $11.50 / -0.48 (-4.01%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts 03/25/21 Bioventus - BVS
Hot Stocks	Abcam announces change of accounting reference date » 07:29 03/08/21 03/08 07:29 03/08/21 07:29 ABCM Abcam $21.10 / +0.13 (+0.62%) Before the end of this… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ABCM Abcam $21.10 / +0.13 (+0.62%) 11/03/20 Abcam to retain existing LTIP metrics, targets ABCM Abcam $21.10 / +0.13 (+0.62%) 01/12/21 RBC Capital Abcam upgraded to Outperform from Sector Perform at RBC Capital 11/16/20 William Blair Abcam initiated with an Outperform at William Blair 11/16/20 Fly Intel: Top five analyst initiations 11/16/20 Morgan Stanley Abcam initiated with an Equal Weight at Morgan Stanley ABCM Abcam $21.10 / +0.13 (+0.62%) 07:28 Today Abcam reports 1H adjusted EPS 8.1p vs. 13p last year 01/11/21 Abcam sees 1H revenue GBP147.5M vs. GBP138.2M last year 22 Oct ABCM Abcam $21.10 / +0.13 (+0.62%) 10/25/20 Opening Day: McAfee returns to public market with $740M IPO 09:00 Today Abcam - ABCM
Earnings	Abcam reports 1H adjusted EPS 8.1p vs. 13p last year » 07:28 03/08/21 03/08 07:28 03/08/21 07:28 ABCM Abcam $21.10 / +0.13 (+0.62%) Reports 1H revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ABCM Abcam $21.10 / +0.13 (+0.62%) 11/03/20 Abcam to retain existing LTIP metrics, targets ABCM Abcam $21.10 / +0.13 (+0.62%) 01/12/21 RBC Capital Abcam upgraded to Outperform from Sector Perform at RBC Capital 11/16/20 William Blair Abcam initiated with an Outperform at William Blair 11/16/20 Fly Intel: Top five analyst initiations 11/16/20 Morgan Stanley Abcam initiated with an Equal Weight at Morgan Stanley ABCM Abcam $21.10 / +0.13 (+0.62%) 01/11/21 Abcam sees 1H revenue GBP147.5M vs. GBP138.2M last year 22 Oct ABCM Abcam $21.10 / +0.13 (+0.62%) 10/25/20 Opening Day: McAfee returns to public market with $740M IPO 09:00 Today Abcam - ABCM
Upgrade	Cenovus Energy upgraded to Neutral from Underweight at JPMorgan » 07:28 03/08/21 03/08 07:28 03/08/21 07:28 CVE Cenovus Energy $8.21 / +0.345 (+4.39%) JPMorgan analyst Phil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CVE Cenovus Energy $8.21 / +0.345 (+4.39%) 01/28/21 Cenovus Energy 2021 budget to achieve nearly $1B of synergies in first year 01/04/21 Suncor to record $425M non-cash after-tax impairment charge in Q4 01/04/21 Cenovus Energy closes transaction to combine with Husky Energy 12/21/20 Cenovus Energy, Husky Energy announce regulatory approvals for combination CVE Cenovus Energy $8.21 / +0.345 (+4.39%) 02/19/21 National Bank Cenovus Energy price target raised to C$13.50 from C$13 at National Bank 01/29/21 National Bank Cenovus Energy price target lowered to C$13 from C$13.50 at National Bank 01/29/21 TD Securities Cenovus Energy price target lowered to C$10 from C$10.50 at TD Securities 01/15/21 CIBC Cenovus Energy initiated with Outperformer, C$11 target at CIBC CVE Cenovus Energy $8.21 / +0.345 (+4.39%) 02/09/21 Cenovus Energy reports Q4 EPS (12c), consensus (2c) 10/29/20 Cenovus Energy reports Q3 EPS (37c), consensus (2c) CVE Cenovus Energy $8.21 / +0.345 (+4.39%) 10/26/20 Fly Intel: Wall Street's top stories for Monday 10/26/20 Fly Intel: Wall Street's top stories at midday 04/06/21 Capp Energy Virtual Symposium
Downgrade	Entergy downgraded to Sector Weight at KeyBanc on growing regulatory concerns » 07:27 03/08/21 03/08 07:27 03/08/21 07:27 ETR Entergy $89.13 / +1.515 (+1.73%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ETR Entergy $89.13 / +1.515 (+1.73%) 02/28/21 Fly Intel: Top five weekend stock stories 12/23/20 Entergy, Holtec file request to transfer Palisades nuclear plant post-shutdown 10/30/20 Entergy increases quarterly dividend payment by 2c to 95c per share 09/24/20 Entergy commits to achieving net-zero carbon emissions by 2050 ETR Entergy $89.13 / +1.515 (+1.73%) 04:44 Today KeyBanc Entergy downgraded to Sector Weight from Overweight at KeyBanc 01/27/21 Mizuho Entergy price target lowered to $105 from $110 at Mizuho 01/21/21 Evercore ISI Entergy upgraded to Outperform from In Line at Evercore ISI 11/17/20 Mizuho Entergy price target raised to $119 from $109 at Mizuho ETR Entergy $89.13 / +1.515 (+1.73%) 02/24/21 Entergy sees FY21 adjusted EPS $5.80-$6.10, consensus $5.89 02/24/21 Entergy reports Q4 adjusted EPS 71c, consensus 66c 10/28/20 Entergy narrows FY20 adjusted EPS view to $5.60-$5.70 from $5.45-$5.75 10/28/20 Entergy reports Q3 adjusted EPS $2.44, consensus $2.42

Recommendations	Westlake Chemical price target raised to $98 from $92 at JPMorgan » 07:26 03/08/21 03/08 07:26 03/08/21 07:26 WLK Westlake Chemical $89.41 / +4.315 (+5.07%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 11/18/20 Westlake Chemical appoints Roger Kearns as COO, effective January 1 WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 02/24/21 Wells Fargo Westlake Chemical price target raised to $104 from $95 at Wells Fargo 01/13/21 Deutsche Bank Westlake Chemical price target raised to $104 from $90 at Deutsche Bank 12/21/20 Fly Intel: Top five analyst upgrades 12/21/20 JPMorgan Westlake upgraded on 'snug' polyethylene market at JPMorgan WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 02/23/21 Westlake Chemical Partners reports Q4 EPS 87c, consensus 73c 11/03/20 Westlake Chemical reports Q3 EPS 45c, consensus 46c WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street
Hot Stocks	AirBoss of America to acquire BlackBox Biometrics for $27M » 07:26 03/08/21 03/08 07:26 03/08/21 07:26 ABSSF AirBoss of America $0.00 / + (+0.00%) AirBoss of America Corp.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/21/21 Stifel AirBoss of America price target lowered to C$23.75 from C$33 at Stifel 01/20/21 CIBC AirBoss of America price target lowered to C$28 from C$31 at CIBC 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M
Recommendations	LyondellBasell price target raised to $120 from $104 at JPMorgan » 07:25 03/08/21 03/08 07:25 03/08/21 07:25 LYB LyondellBasell $107.88 / +3.86 (+3.71%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LYB LyondellBasell $107.88 / +3.86 (+3.71%) 02/17/21 Halliburton appoints Bob Patel to board of directors 01/26/21 LyondellBasell, Sinopec Shanghai sign agreement to form JV to produce PO and SM 12/07/20 LyondellBasell, SUEZ jointly announce the acquisition of TIVACO 10/02/20 LyondellBasell to acquire 50% of Sasol Louisiana assets for $2B in JV agreement LYB LyondellBasell $107.88 / +3.86 (+3.71%) 03/02/21 Fly Intel: Top five analyst upgrades 03/02/21 Wells Fargo LyondellBasell upgraded to Overweight from Equal Weight at Wells Fargo 03/01/21 Alembic Global LyondellBasell upgraded to Overweight from Neutral at Alembic Global 02/22/21 BofA LyondellBasell upgraded to Buy from Neutral at BofA LYB LyondellBasell $107.88 / +3.86 (+3.71%) 01/29/21 LyondellBasell reports Q4 ex-items EPS $2.19, consensus $1.36 10/30/20 LyondellBasell reports Q3 ex-items EPS $1.27, consensus $1.12 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open LYB LyondellBasell $107.88 / +3.86 (+3.71%) 11/13/20 Disney upgrade among today's top calls on Wall Street
Downgrade	Mapletree Logistics Trust downgraded to Underweight from Overweight at JPMorgan » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 MAPGF Mapletree Logistics Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	Wedbush bullish on Nuvation Bio, initiates with an Outperform » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 NUVB Nuvation Bio $10.86 / +0.36 (+3.43%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NUVB Nuvation Bio $10.86 / +0.36 (+3.43%) 06:29 Today Wedbush Nuvation Bio initiated with an Outperform at Wedbush 05:45 Today BTIG Nuvation Bio initiated with a Buy at BTIG 04:57 Today BMO Capital Nuvation Bio initiated with an Outperform at BMO Capital

Hot Stocks	Akoustis announces discharge of indentures related to convertible notes » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 AKTS Akoustis $12.26 / -0.58 (-4.52%) Akoustis Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AKTS Akoustis $12.26 / -0.58 (-4.52%) 03/03/21 Akoustis awarded design win for XBAW filters from CBRS customer 02/01/21 Akoustis locks process flow for wafer-level-chip-scale-package 01/29/21 Akoustis receives volume order for XBAW WiFi 6E filter solutions 12/16/20 Akoustis receives first 5G mobile orders for XBAW filters AKTS Akoustis $12.26 / -0.58 (-4.52%) 02/23/21 Roth Capital Akoustis equity financing improves balance sheet, says Roth Capital 02/02/21 Lake Street Akoustis price target raised to $19 from $10 at Lake Street 02/01/21 Roth Capital Akoustis price target raised to $25 from $16 at Roth Capital 01/28/21 Oppenheimer Akoustis price target raised to $20 from $15 at Oppenheimer AKTS Akoustis $12.26 / -0.58 (-4.52%) 02/01/21 Akoustis reports Q2 EPS (30c), consensus (23c) 11/02/20 Akoustis reports Q4 non-GAAP EPS (23c), consensus (24c) 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference AKTS Akoustis $12.26 / -0.58 (-4.52%) 01/29/21 Akoustis options imply 10.9% move in share price post-earnings 01/07/21 Largest borrow rate increases among liquid names
Initiation	Viant initiated with a Buy at Needham » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 DSP Viant $41.41 / -0.5 (-1.19%) Needham analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly DSP Viant $41.41 / -0.5 (-1.19%) 06:29 Today Needham Viant initiated with a Buy at Needham 06:28 Today JMP Securities Viant initiated with a Market Perform at JMP Securities 06:03 Today BofA Viant initiated with a Neutral at BofA 05:49 Today Canaccord Viant initiated with a Buy at Canaccord 10 Feb DSP Viant $41.41 / -0.5 (-1.19%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts
Downgrade	Mapletree Industrial Trust downgraded to Underweight from Overweight at JPMorgan » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MAPIF Mapletree Industrial Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MAPIF Mapletree Industrial Trust $0.00 / + (+0.00%) 01/11/21 HSBC Mapletree Industrial Trust upgraded to Buy from Hold at HSBC 04/28/20 Jefferies Mapletree Industrial Trust downgraded to Hold from Buy at Jefferies
Hot Stocks	Mateon Therapeutics completes enrollment for OT-101 study » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MATN Mateon Therapeutics $0.00 / + (+0.00%) Mateon Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News MATN Mateon Therapeutics $0.00 / + (+0.00%) 03/01/21 Mateon Therapeutics, Windlas publish PulmoHeal clinical data 02/22/21 Mateon Therapeutics, Windlas Biotech launch PulmoHeal in India 02/02/21 Mateon Therapeutics announces publication of ARTI-19 interim data 02/01/21 Mateon Therapeutics launches AI telemedicine platform for PMS
Upgrade	Mapletree Commercial Trust upgraded to Overweight from Neutral at JPMorgan » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MPCMF Mapletree Commercial Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MPCMF Mapletree Commercial Trust $0.00 / + (+0.00%) 01/11/21 HSBC Mapletree Commercial Trust downgraded to Hold from Buy at HSBC

Hot Stocks	Evolv Technology to be publicly traded through NewHold Investment Corp. merger » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) Evolv Technology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 07:01 Today NewHold Investment Corp (Class A Stock) trading halted, news dissemination 03/07/21 Fly Intel: Top five weekend stock stories NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 03/07/21 Evolv going public in $1.7B SPAC merger, WSJ reports
Hot Stocks	Intersect ENT: CMS combines SINUVA sinus implant coverage under distinct code » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 XENT Intersect ENT $23.77 / +0.8 (+3.48%) Intersect ENT announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events XENT Intersect ENT $23.77 / +0.8 (+3.48%) 11/17/20 Intersect ENT announces new leadership appointments 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/10/20 Intersect ENT signs Sinuva distribution agreement with AllianceRx Walgreens XENT Intersect ENT $23.77 / +0.8 (+3.48%) 01/15/21 Piper Sandler Intersect ENT price target raised to $23 from $17 at Piper Sandler 01/11/21 Canaccord Intersect ENT upgraded to Buy from Hold at Canaccord 11/19/20 BTIG Intersect ENT upgraded to Buy from Neutral at BTIG 11/02/20 Piper Sandler Intersect ENT price target raised to $17 from $16 at Piper Sandler XENT Intersect ENT $23.77 / +0.8 (+3.48%) 01/12/21 Intersect ENT reports preliminary Q4 revenue $27.7M-$28.1M, consensus $27.67M 11/02/20 Intersect ENT reports Q3 EPS (35c), consensus (45c) 10/15/20 Intersect ENT sees Q4 revenue about 85%-90% of Q4 in FY19 10/15/20 Intersect ENT sees Q3 revenue $22.4M-$22.8M, consensus $21.4M 03/09/21 Intersect ENT - XENT
Downgrade	Keppel DC REIT downgraded to Underweight from Overweight at JPMorgan » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 KPDCF Keppel DC REIT $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Athira Pharma appoints Barbara Kosacz to board of directors » 07:20 03/08/21 03/08 07:20 03/08/21 07:20 ATHA Athira Pharma $19.13 / -0.13 (-0.67%) , KRON Kronos Bio $28.01 / -0.955 (-3.30%) Athira Pharma (ATHA)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 12/14/20 Athira says ATH platform can potentially address several clinical applications 12/14/20 LIFT-AD Phase 2/3, ACT-AD patient dosing among 2020 milestones, Athira says 12/14/20 Athira Pharma CEO says timelines 'remained on track' despite COVID 12/14/20 Urgent need remains for Alzheimer's treatment, Athira CEO says KRON Kronos Bio $28.01 / -0.955 (-3.30%) 03/04/21 Kronos Bio to initiate Phase 3 trial of entospletinib in mid-2021 02/25/21 Kronos Bio announces first patient dosed in Phase 1/2 KB-0742 trial 01/26/21 Kronos Bio appoints Marianne De Backer to board of directors 12/08/20 Kronos Bio appoints Pasit Phiasivongsa as SVP, pharmaceutical development ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 10/13/20 Jefferies Athira Pharma initiated with a Buy at Jefferies 10/13/20 JMP Securities Athira Pharma initiated with an Outperform at JMP Securities 10/13/20 Stifel Athira Pharma initiated with a Buy at Stifel 10/13/20 Goldman Sachs Athira Pharma initiated with a Buy at Goldman Sachs KRON Kronos Bio $28.01 / -0.955 (-3.30%) 11/03/20 Fly Intel: Top five analyst initiations 11/03/20 Jefferies Kronos Bio initiated with a Buy at Jefferies 11/03/20 Piper Sandler Kronos Bio initiated with an Overweight at Piper Sandler 11/03/20 Goldman Sachs Kronos Bio initiated with a Buy at Goldman Sachs ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 11/12/20 Athira Pharma reports Q EPS ($1.12), consensus (25c) KRON Kronos Bio $28.01 / -0.955 (-3.30%) 11/18/20 Kronos Bio reports Q3 EPS ($6.48), consensus ($1.47) 21 Jan 09 Oct 18 Sep ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 12/14/20 Meet Athira Pharma: A Fly exclusive interview with CEO Leen Kawas 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever KRON Kronos Bio $28.01 / -0.955 (-3.30%) 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions KRON KRON Kronos Bio $28.01 / -0.955 (-3.30%) 01/28/21 new option listings on January 28th
Hot Stocks	Chemours announces project to reduce HFC-23 emissions at Kentucky site » 07:20 03/08/21 03/08 07:20 03/08/21 07:20 CC Chemours $27.43 / +1.32 (+5.06%) The Chemours Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CC Chemours $27.43 / +1.32 (+5.06%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 01/22/21 DuPont, Corteva and Chemours resolve legal disputes from 2015 spin-off 12/14/20 Energy Fuels enters three-year monazite supply agreement with Chemours 11/03/20 Chemours says all sites remain operational CC Chemours $27.43 / +1.32 (+5.06%) 02/17/21 Citi Chemours price target raised to $29 from $27 at Citi 02/16/21 BMO Capital Chemours price target raised to $38 from $33 at BMO Capital 01/08/21 RBC Capital Chemours upgraded to Outperform from Sector Perform at RBC Capital 12/04/20 Barclays Chemours downgraded to Equal Weight ahead of PFAS news flow at Barclays CC Chemours $27.43 / +1.32 (+5.06%) 02/11/21 Chemours sees FY21 adjusted EPS $2.40-$3.12, consensus $2.60 02/11/21 Chemours reports Q4 adjusted EPS 61c, consensus 41c 11/03/20 Chemours reports Q3 adjusted EPS 47c, consensus 33c 11/03/20 Notable companies reporting after market close CC Chemours $27.43 / +1.32 (+5.06%) 11/03/20 Fly Intel: After-Hours Movers CC Chemours $27.43 / +1.32 (+5.06%) 02/02/21 Two new option listings on February 2nd 02/01/21 Three new option listings and five option delistings on February 1st 11/03/20 Chemours options imply 13.6% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

Xpeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
NERV
Today at 08:30

Minerva - NERV Conference Calls
CI
Today at 08:30

CIGNA Corporation Firm Sponsored Meetings
ABCM
Today at 09:00

Abcam - ABCM Conference Calls
Today at 10:00

Wholesale Inventories (Preliminary) M/M: January 2021 Government Event
NINE
Today at 10:00

Nine Energy Service - NINE Conference Calls
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls
FOLD
Today at 10:00

Amicus - FOLD Conference Calls
PERI
Today at 10:00

Perion Network Ltd. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

Diamonds Fund ETF: Pivot points

TODAY'S FREE FLY STORIES

Get Full Fly Access